1,9-dimethylmethylene blue has been researched along with interleukin-8 in 1 studies
| Studies (1,9-dimethylmethylene blue) | Trials (1,9-dimethylmethylene blue) | Recent Studies (post-2010) (1,9-dimethylmethylene blue) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 81 | 1 | 6 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, N; Duesterdieck-Zellmer, KF; Ott, JF | 1 |
1 other study(ies) available for 1,9-dimethylmethylene blue and interleukin-8
| Article | Year |
|---|---|
Concentration-dependent effects of tiludronate on equine articular cartilage explants incubated with and without interleukin-1β.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Cartilage, Articular; Chondrocytes; Dinoprostone; Diphosphonates; Dose-Response Relationship, Drug; Down-Regulation; Glycosaminoglycans; Horse Diseases; Horses; Immunoenzyme Techniques; In Situ Nick-End Labeling; In Vitro Techniques; Interleukin-1beta; Interleukin-6; Interleukin-8; Matrix Metalloproteinases; Methylene Blue; Osteoarthritis; Recombinant Proteins | 2012 |